Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study

Rheumatol Ther. 2023 Jan 4. doi: 10.1007/s40744-022-00530-0. Online ahead of print.


PMID:36598735 | DOI:10.1007/s40744-022-00530-0

Full Text Link: Read More

Generated by Feedzy